Дмитренко ІВ. Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia. PEB [Internet]. 2018 Jun. 27 [cited 2026 Jun. 14];(1). Available from: http://jrnl.kai.edu.ua/index.php/ecobiotech/article/view/12851